Merck expects to produce 10M doses of molnupiravir by 2021-end, hopes of reducing risk of hospitalization and death by 50%

Share
AuthorPosted at
Merck plans to apply for Emergency Use Authorization (EUA) to the U.S. FDA as soon as possible based on these findings and plans to submit marketing applications to other regulatory bodies worldwide.

from India Infoline News Service https://ift.tt/3aj27K5
Post a Comment
Labels

Comments